Carbon Monoxide Toxicity Treatment & Management
- Author: Guy N Shochat, MD; Chief Editor: Asim Tarabar, MD more...
Prehospital care includes the following:
Promptly remove the patient from continued exposure and immediately institute oxygen therapy with a nonrebreather mask.
Perform intubation for the comatose patient or, if necessary for airway protection, and provide 100% oxygen therapy.
Institute cardiac monitoring. Pulse oximetry, although not useful in detecting carboxyhemoglobin (HbCO), is still important because a low saturation causes even greater apprehension in this setting.
Give notification to the emergency department for comatose or unstable patients because rapid or direct transfer to a hyperbaric center may be indicated.
If possible, obtain ambient CO measurements from fire department or utility company personnel, when present.
Early blood samples may provide much more accurate correlation between HbCO and clinical status; however, do not delay oxygen administration to acquire them.
Obtain an estimate of exposure time, if possible.
Avoid exertion to limit tissue oxygen demand.
Emergency Department Care
Considerations in emergency department (ED) care include the following:
Cardiac monitor: Sudden death has occurred in patients with severe arteriosclerotic disease at HbCO levels of only 20%.
Pulse oximetry: HbCO absorbs light almost identically to that of oxyhemoglobin. Although a linear drop in oxyhemoglobin occurs as HbCO level rises, pulse oximetry will not reflect it. Pulse oximetry gap, the difference between the saturation as measured by pulse oximetry and one measured directly, is equal to the HbCO level. However, pulse CO-oximetry units are available that can screen for CO toxicity at the bedside.
Continue 100% oxygen therapy until the patient is asymptomatic and HbCO levels are below 10%. In patients with cardiovascular or pulmonary compromise, lower thresholds of 2% have been suggested.
Calculate a gross estimate of the necessary duration of therapy using the initial level and half-life of 30-90 minutes at 100% oxygen.
In uncomplicated intoxications, venous HbCO levels and oxygen therapy are likely sufficient. Evaluate patients with significant cardiovascular disease and initial HbCO levels above 15% for myocardial ischemia and infarction.
Consider immediate transfer of patients with levels above 40% or cardiovascular or neurologic impairment to a hyperbaric facility, if feasible. Persistent impairment after 4 hours of normobaric oxygen therapy necessitates transfer to a hyperbaric center. Pregnant patients should be considered for hyperbaric treatment at lower carboxyhemoglobin levels (above 15%). Complicated issues of treatment of fetomaternal poisoning are discussed in Special Concerns.
Serial neurologic examinations, including funduscopy, CT scans, and, possibly, MRI, are important in detecting the development of cerebral edema. Cerebral edema requires intracranial pressure (ICP) and invasive blood pressure monitoring to further guide therapy. Head elevation, mannitol, and moderate hyperventilation to 28-30 mm Hg PCO 2 are indicated in the initial absence of ICP monitoring. Glucocorticoids have not been proven efficacious, yet the negative aspects of their use in severe cases are limited.
Do not aggressively treat acidosis with a pH above 7.15 because it results in a rightward shift in the oxyhemoglobin dissociation curve, increasing tissue oxygen availability. Acidosis generally improves with oxygen therapy.
In patients who fail to improve clinically, consider other toxic inhalants or thermal inhalation injury as contributing factors. Be aware that the nitrites used in cyanide kits cause methemoglobinemia, shifting the dissociation curve leftward and further inhibiting oxygen delivery at the tissue level. Combined intoxications of cyanide and CO may be treated with sodium thiosulfate 12.5 g intravenously to prevent the leftward shift.
Admit patients to a monitored setting and evaluate acid-base status if HbCO levels are 30-40% or above 25% with associated symptoms.
Hyperbaric Oxygen Therapy
Locate the nearest hyperbaric oxygen center by contacting the Divers Alert Network (DAN) at Duke University at (919) 684-2948. However, note that a survey of hyperbaric programs in the United States found that only 43 of 361 centers (11.9%) had equipment, intravenous infusion pumps and ventilators, and staff necessary to treat high-acuity patients.
Hyperbaric oxygen therapy (HBO) currently rests at the center of controversy surrounding management of CO poisoning. Increased elimination of HbCO clearly occurs. Certain studies proclaim major reductions in delayed neurologic sequelae, cerebral edema, pathologic central nervous system (CNS) changes, and reduced cytochrome oxidase impairment. Despite these individual claims, systematic reviews have not revealed a clear benefit of HBO, so no clear guidelines for its use have been determined.[27, 28]
Presently, universal treatment criteria do not exist; however, a survey of directors of North American HBO facilities with 85% responding demonstrates some consensus. The most common selection criteria (regardless of HbCO level) include the following:
Transient loss of consciousness (77%)
Ischemic ECG changes (91%)
Focal neurologic deficits (94%)
Abnormal neuropsychiatric test results (91%).
Ninety-two percent of HBO facility directors use HBO for headache, nausea, and HbCO levels above 40%; yet only 62% have a specific minimum HbCO level in asymptomatic patients. One half of the centers place a time limit on delay of treatment in patients with transient loss of consciousness alone.
HBO at 3 atm raises the amount of oxygen dissolved in the serum to 6.8%, enough to sustain cerebral metabolism. Elimination half-life is reduced to 15-23 minutes. Elimination half-life of CO from methylene chloride intoxication of 13 hours at room air temperature is reduced to 5.8 hours.
Chambers are small monoplace hulls, allowing space for a single patient in a supine position who can be viewed through a window at the head, or they are acrylic walled and allow full visualization. Many of these monoplace chambers allow for care of critically ill patients, including intravenous lines, arterial lines, and ventilator. Others are large multiplace chambers that permit ventilation equipment and allow medical teams to accompany the patient. A monoplace chamber is shown below.
Treatment regimens usually involve 100% oxygen at 2.4-3 atm for 90-120 minutes. Re-treatment, although controversial, may be performed for acutely and chronically persistent symptoms. One study suggests that degree of metabolic acidosis can predict the need for re-treatment.
Complications of therapy include decompression sickness, sinus and middle ear barotrauma, seizure, progression of pneumothorax to tension pneumothorax, gas embolism, reversible visual refractive changes, and complications related to transport of unstable patients.
For treatment of complications from therapy, decongestants are useful, prophylactic myringotomy is common and a requirement for intubated patients, and chest tube placement is mandatory with pneumothorax. Exercise caution in patients who have experienced chest compressions, central venous catheterization, intubation, and positive pressure ventilation. Seizures are most often secondary to oxygen toxicity and do not mandate anticonvulsant therapy or discontinuation of HBO therapy.
In multiplace chambers, seizure therapy consists of removing the oxygen mask. In monoplace chambers, decompression lowers oxygen concentration. It is crucial not to do this during the tonic phase of the seizure because it may cause pulmonary barotrauma secondary to gas expansion in the lungs.
A 10-year retrospective study found that transfer to an HBO facility did not need to be delayed for concern of cardiac arrest, respiratory arrest, myocardial infarction, or worsening mental status if they had not occurred during initial resuscitation; however, hypotension, dysrhythmia, seizure, emesis, and agitation were of concern in transit as well as in initial resuscitation.
Survivors of CO poisoning are at risk for a range of neurologic and psychiatric complications, including the following :
Impaired intellectual function
Short-term memory loss
Parkinson disease 
Survivors of intentional CO poisoning are at extreme risk for subsequent completion of suicide.
Anderson AR, Centers for Disease Control and Prevention (CDC). Top five chemicals resulting in injuries from acute chemical incidents—Hazardous Substances Emergency Events Surveillance, nine states, 1999-2008. MMWR Suppl. 2015 Apr 10. 64 (2):39-46. [Medline].
Hampson NB, Piantadosi CA, Thom SR, Weaver LK. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med. 2012 Dec 1. 186 (11):1095-101. [Medline]. [Full Text].
Hampson NB, Dunn SL. Carbon Monoxide Poisoning from Portable Electrical Generators. J Emerg Med. 2015 Aug. 49 (2):125-9. [Medline].
Workplace Safety and Health Topic:Carbon Monoxide (CO) Dangers in Boating. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/niosh/topics/coboating/. August 16, 2013; Accessed: May 5, 2016.
Hawkes AP, McCammon JB, Hoffman RE. Indoor use of concrete saws and other gas-powered equipment. Analysis of reported carbon monoxide poisoning cases in Colorado. J Occup Environ Med. 1998 Jan. 40(1):49-54. [Medline].
Nager EC, O'Connor RE. Carbon monoxide poisoning from spray paint inhalation. Acad Emerg Med. 1998 Jan. 5(1):84-6. [Medline].
Suner S, Jay G. Carbon monoxide has direct toxicity on the myocardium distinct from effects of hypoxia in an ex vivo rat heart model. Acad Emerg Med. 2008 Jan. 15(1):59-65. [Medline].
Sircar K, Clower J, Shin MK, Bailey C, King M, Yip F. Carbon monoxide poisoning deaths in the United States, 1999 to 2012. Am J Emerg Med. 2015 Sep. 33 (9):1140-5. [Medline].
Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol (Phila). 2015. 53 (10):962-1147. [Medline]. [Full Text].
Routley VH, Ozanne-Smith J. The impact of catalytic converters on motor vehicle exhaust gas suicides. Med J Aust. 1998 Jan 19. 168(2):65-7. [Medline].
QuickStats: Average Annual Number of Deaths and Death Rates from Unintentional, Non–Fire-Related Carbon Monoxide Poisoning,*† by Sex and Age Group — United States, 1999–2010. MMWR Morb Mortal Wkly Rep. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6303a6.htm?s_cid=mm6303a6_e. Accessed: September 30, 2014.
Wrenn K, Conners GP. Carbon monoxide poisoning during ice storms: a tale of two cities. J Emerg Med. 1997 Jul-Aug. 15(4):465-7. [Medline].
Centers for Disease Control and Prevention (CDC). Notes from the field: carbon monoxide exposures reported to poison centers and related to hurricane Sandy - Northeastern United States, 2012. MMWR Morb Mortal Wkly Rep. 2012 Nov 9. 61 (44):905. [Medline]. [Full Text].
Cook M, Simon PA, Hoffman RE. Unintentional carbon monoxide poisoning in Colorado, 1986 through 1991. Am J Public Health. 1995 Jul. 85 (7):988-90. [Medline].
Cone DC, MacMillan D, Parwani V, Van Gelder C. Threats to life in residential structure fires. Prehosp Emerg Care. 2008 Jul-Sep. 12(3):297-301. [Medline].
Hampson NB. Noninvasive pulse CO-oximetry expedites evaluation and management of patients with carbon monoxide poisoning. Am J Emerg Med. 2012 May 23. [Medline].
Perrone J, Hoffman RS. Falsely elevated carboxyhemoglobin levels secondary to fetal hemoglobin. Acad Emerg Med. 1996 Mar. 3(3):287-9. [Medline].
Cha YS, Kim H, Hwang SO, Kim JY, Kim YK, Choi EH, et al. Incidence and patterns of cardiomyopathy in carbon monoxide-poisoned patients with myocardial injury. Clin Toxicol (Phila). 2016 Apr 11. 1-7. [Medline].
Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD. Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA. 2006 Jan 25. 295(4):398-402. [Medline].
Damlapinar R, Arikan FI, Sahin S, Dallar Y. Lactate Level Is More Significant Than Carboxihemoglobin Level in Determining Prognosis of Carbon Monoxide Intoxication of Childhood. Pediatr Emerg Care. 2015 Jul 14. 37 (1):1-7. [Medline].
So GM, Kosofsky BE, Southern JF. Acute hydrocephalus following carbon monoxide poisoning. Pediatr Neurol. 1997 Oct. 17(3):270-3. [Medline].
Chin W, Jacoby L, Simon O, Talati N, Wegrzyn G, Jacoby R, et al. Hyperbaric programs in the United States: Locations and capabilities of treating decompression sickness, arterial gas embolisms, and acute carbon monoxide poisoning: survey results. Undersea Hyperb Med. 2016 Jan-Feb. 43 (1):29-43. [Medline].
Buckley NA, Isbister GK, Stokes B, Juurlink DN. Hyperbaric oxygen for carbon monoxide poisoning : a systematic review and critical analysis of the evidence. Toxicol Rev. 2005. 24(2):75-92. [Medline].
Buckley NA, Juurlink DN, Isbister G, Bennett MH, Lavonas EJ. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev. 2011 Apr 13. 4:CD002041. [Medline].
Turner M, Esaw M, Clark RJ. Carbon monoxide poisoning treated with hyperbaric oxygen: metabolic acidosis as a predictor of treatment requirements. J Accid Emerg Med. 1999 Mar. 16 (2):96-8. [Medline].
Sloan EP, Murphy DG, Hart R, Cooper MA, Turnbull T, Barreca RS, et al. Complications and protocol considerations in carbon monoxide-poisoned patients who require hyperbaric oxygen therapy: report from a ten-year experience. Ann Emerg Med. 1989 Jun. 18 (6):629-34. [Medline].
Lai CY, Huang YW, Tseng CH, Lin CL, Sung FC, Kao CH. Patients With Carbon Monoxide Poisoning and Subsequent Dementia: A Population-Based Cohort Study. Medicine (Baltimore). 2016 Jan. 95 (1):e2418. [Medline].
Lai CY, Chou MC, Lin CL, Kao CH. Increased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort study. Medicine (Baltimore). 2015 May. 94 (19):e869. [Medline].
Krenzelok EP, Roth R, Full R. Carbon monoxide ... the silent killer with an audible solution. Am J Emerg Med. 1996 Sep. 14(5):484-6. [Medline].
Hampson NB, Piantadosi CA, Thom SR, Weaver LK. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med. 2012 Dec 1. 186(11):1095-101. [Medline].
Bourtros AR, Hoyt JL. Management of carbon monoxide poisoning in the absence of hyperbaric oxygenation chamber. Crit Care Med. 1976 May-Jun. 4(3):144-7. [Medline].
Bozeman WP, Myers RA, Barish RA. Confirmation of the pulse oximetry gap in carbon monoxide poisoning. Ann Emerg Med. 1997 Nov. 30(5):608-11. [Medline].
Dogan N, Savrun A, Levent S, Günaydin G, Celik G, Akküçük H, et al. Can initial lactate levels predict the severity of unintentional carbon monoxide poisoning?. Hum Exp Toxicol. 2014 Jun 27. [Medline].
Inagaki T, Ishino H, Seno H, Umegae N, Aoyama T. A long-term follow-up study of serial magnetic resonance images in patients with delayed encephalopathy after acute carbon monoxide poisoning. Psychiatry Clin Neurosci. 1997 Dec. 51(6):421-3. [Medline].
Jones JS, Lagasse J, Zimmerman G. Computed tomographic findings after acute carbon monoxide poisoning. Am J Emerg Med. 1994 Jul. 12(4):448-51. [Medline].
Leem JH, Kaplan BM, Shim YK, et al. Exposures to air pollutants during pregnancy and preterm delivery. Environ Health Perspect. 2006 Jun. 114(6):905-10. [Medline].
Raub JA, Benignus VA. Carbon monoxide and the nervous system. Neurosci Biobehav Rev. 2002 Dec. 26(8):925-40. [Medline].
Reisdorff EJ, Wiegenstein JG. Carbon monoxide poisoning. Tintinalli JE, et al, eds. Emergency Medicine: A Comprehensive Study Guide. 4th ed. New York, NY: McGraw-Hill; 1996. 914-9.
Suner S, Partridge R, Sucov A, et al. Non-invasive pulse CO-oximetry screening in the emergency department identifies occult carbon monoxide toxicity. J Emerg Med. 2008 May. 34(4):441-50. [Medline].
Van Hoesen K. Hyperbaric oxygen therapy. Rosen P, et al, eds. Emergency Medicine: Concepts and Clinical Practice. 2nd ed. St. Louis, Mo: Mosby-Year Book; 1998. 1032-42.